News on immunohistochemistry and other tissue-based testing methods.
The Finnish life sciences company hopes to complete development of the device in 2019 and will focus initially on applying it to breast cancer surgery.
With the NeoLSD MSMS kit, labs can leverage tandem mass spec technology, which reduces sample prep and analysis times, to run hundreds of tests per day.
Oxford University Hospitals NHS Foundation Trust will use the Philips Intellisite system to create a digital pathology network across a number of UK hospitals.
Revenues for Roche Diagnostics totaled CHF 6.26 billion for H1, driven primarily by demand for immunodiagnostic solutions.
The system is designed to identify various cell types and features in whole-slide images of prostate core needle biopsies.
